TNFAIP3 and acute lymphoblastic leukemia: In acute lymphoblastic leukemia, miR-125b specifically targets tumor necrosis factor-alpha-induced protein 3 (TNFAIP3), which inhibits CD4+ T cell proliferation, boosts glycolysis in T cells, and markedly increases oxygen consumption (52).